Cellebrite DI Ltd. (NASDAQ:CLBT) Receives $13.17 Average Target Price from Analysts

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have updated their coverage on […]

Leave a Reply

Your email address will not be published.

Previous post Maplewood domestic violence shelter to add space for dogs, cats
Next post Hub Group, Inc. (NASDAQ:HUBG) Given Consensus Recommendation of “Hold” by Brokerages